HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

Abstract
Candesartan has been reported to have a protective effect on cerebral ischemia in vivo and in human ischemic stroke. We studied the direct effects of candesartan on blood-brain barrier (BBB) function with our in vitro monolayer model generated using rat brain capillary endothelial cells (RBECs). The in vitro BBB model was subjected to normoxia or 6-h oxygen glucose deprivation (OGD)/24-h reoxygenation, with or without candesartan. 6-h OGD/24-h reoxygenation decreased transendothelial electrical resistance and increased the endothelial permeability for sodium fluorescein in RBEC monolayers. Candesartan (10 nM) improved RBEC barrier dysfunction induced by 6-h OGD/24-h reoxygenation. Immunostaining and immunoblotting analysis indicated that the effect of candesartan on barrier function under 6-h OGD/24-h reoxygenation was not related to the expression levels of tight junction proteins. However, candesartan affected RBEC morphological changes induced by 6-h OGD/24-h reoxygenation. We analyzed oxidative stress and cell viability using chemical reagents. Candesartan improved cell viability following 6-h OGD/24-h reoxygenation, whereas candesartan had no effect on oxidative stress. These results show that candesartan directly improves cell function and viability of brain capillary endothelial cells under OGD/reoxygenation, suggesting that the protective effects of candesartan on ischemic stroke are related to protection of the BBB.
AuthorsGohei So, Shinsuke Nakagawa, Yoichi Morofuji, Takeshi Hiu, Kentaro Hayashi, Kunihiko Tanaka, Kazuhiko Suyama, Maria A Deli, Izumi Nagata, Takayuki Matsuo, Masami Niwa
JournalCellular and molecular neurobiology (Cell Mol Neurobiol) Vol. 35 Issue 4 Pg. 563-72 (May 2015) ISSN: 1573-6830 [Electronic] United States
PMID25547389 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzimidazoles
  • Biphenyl Compounds
  • Nitrates
  • Nitrites
  • Reactive Oxygen Species
  • Tetrazoles
  • Tight Junction Proteins
  • candesartan
Topics
  • Animals
  • Benzimidazoles (pharmacology)
  • Biphenyl Compounds
  • Blood-Brain Barrier (drug effects, pathology)
  • Brain Ischemia (pathology)
  • Cell Survival (drug effects)
  • Electric Impedance
  • Endothelial Cells (drug effects, metabolism, pathology)
  • Nitrates (metabolism)
  • Nitrites (metabolism)
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)
  • Tetrazoles (pharmacology)
  • Tight Junction Proteins (metabolism)
  • Tight Junctions (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: